Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v3.21.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net income $ 47,507 $ 65,028
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization expense 22,985 26,619
Straight-line rent and amortization of lease intangibles, net (1,307) (1,064)
Gain on sale of real estate facility   (19,621)
Stock compensation expense 1,780 942
Amortization of financing costs 136 137
Other, net (2,277) (2,034)
Total adjustments 21,317 4,979
Net cash provided by operating activities 68,824 70,007
Cash flows from investing activities    
Capital expenditures to real estate facilities (5,816) (6,944)
Capital expenditures to land and building held for development (10,608) (1,312)
Acquisition of real estate facility   (13,423)
Proceeds from sale of real estate facility   29,266
Net cash (used in) provided by investing activities (16,424) 7,587
Cash flows from financing activities    
Payment of financing costs (78) (97)
Issuance costs (105)  
Cash paid for taxes in lieu of shares upon vesting of restricted stock units (3,197) (3,655)
Cash paid to restricted stock unit holders (164) (182)
Capital contribution to joint venture 159  
Distributions paid to preferred shareholders (12,046) (12,046)
Distributions paid to common shareholders (28,872) (28,817)
Distributions paid to noncontrolling interests-common units (7,671) (7,671)
Distributions paid to noncontrolling interests-joint venture (17) (38)
Net cash used in financing activities (51,991) (52,506)
Net increase in cash and cash equivalents 409 25,088
Cash, cash equivalents and restricted cash at the beginning of the period 70,171 63,874
Cash, cash equivalents and restricted cash at the end of the period 70,580 $ 88,962
Accrued capital expenditures to land and building held for development    
Land and building held for development, net 2,615  
Accrued and other liabilities $ (2,615)